A statistically significant reduction of 45 % in mean AAT levels was observed in the CSF of ALS patients (21.4 μg/ml) as compared to the control group (mean 38.8 μg/ml, p = 0.013). This evidence concerns the gene SERPINA1 and amyotrophic lateral sclerosis.